Prescription for growth: incentives, competition and strategic sustainability at NovaCure Pakistan

Learning outcomes At the end of the case discussion, students should be able to: Case overview/synopsis This case examines the strategic and ethical implications of incentive-driven growth within a multinational pharmaceutical subsidiary operating in Pakistan’s highly competitive, price-regulated and brand-driven market. Set in Karachi in September 2025, the case opens minutes before a quarterly Board meeting at which the protagonist must state his recommendation. NovaCure Pakistan, under the leadership of Chief Marketing Officer Salman Ahmed, achieves a strong commercial turnaround following a restructuring of the sales compensation architecture. The revised incentive model increases the weight of variable pay, leading to accelerated revenue growth, improved field productivity and enhanced morale among top-performing representatives. However, the growth trajectory coincides with escalating commercial expenditure, increasing dependence on incentive payouts, margin pressure and subtle behavioral shifts within the sales force. Competitive intensity, regulatory ambiguity and informal market norms further complicate the sustainability of the current model. At a strategic inflection point, Salman must decide whether to: In the revised case, these strategic directions are deliberately not presented as a formal menu; they emerge implicitly through the positions of the characters. Faisal Qureshi (Sales Director) argues for sustaining the model, Ayesha Malik (Head of Compliance and Governance) presses for recalibration and Salman’s own reflections point toward a longer-term repositioning of the growth strategy. The teaching plan and the analysis of Assignment Question 4 below use these character positions as the entry point for the options debate, so that students infer and construct the options themselves before evaluating them. The case invites students to analyze the interplay between incentives, behavior, cost structures, governance risk and strategic durability in emerging markets. Complexity academic level The case is designed for Master’s-level and executive audiences. It is best suited to: Subject code CSS 11: Strategy.

Authors

Institutions

Publication Details

Journal
Emerald Emerging Markets Case Studies
Published
2026-11-20
DOI
https://doi.org/10.1108/eemcs-03-2026-0144
Primary Topic
Business Strategies and Innovation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prescription for growth: incentives, competition and strategic sustainability at NovaCure Pakistan

Mahnoor Rehman, Umema Naz
Emerald Emerging Markets Case Studies
Business Strategies and Innovation
article

Prescription for growth: incentives, competition and strategic sustainability at NovaCure Pakistan

Mahnoor Rehman, Umema Naz
article en

Abstract

Learning outcomes At the end of the case discussion, students should be able to: Case overview/synopsis This case examines the strategic and ethical implications of incentive-driven growth within a multinational pharmaceutical subsidiary operating in Pakistan’s highly competitive, price-regulated and brand-driven market. Set in Karachi in September 2025, the case opens minutes before a quarterly Board meeting at which the protagonist must state his recommendation. NovaCure Pakistan, under the leadership of Chief Marketing Officer Salman Ahmed, achieves a strong commercial turnaround following a restructuring of the sales compensation architecture. The revised incentive model increases the weight of variable pay, leading to accelerated revenue growth, improved field productivity and enhanced morale among top-performing representatives. However, the growth trajectory coincides with escalating commercial expenditure, increasing dependence on incentive payouts, margin pressure and subtle behavioral shifts within the sales force. Competitive intensity, regulatory ambiguity and informal market norms further complicate the sustainability of the current model. At a strategic inflection point, Salman must decide whether to: In the revised case, these strategic directions are deliberately not presented as a formal menu; they emerge implicitly through the positions of the characters. Faisal Qureshi (Sales Director) argues for sustaining the model, Ayesha Malik (Head of Compliance and Governance) presses for recalibration and Salman’s own reflections point toward a longer-term repositioning of the growth strategy. The teaching plan and the analysis of Assignment Question 4 below use these character positions as the entry point for the options debate, so that students infer and construct the options themselves before evaluating them. The case invites students to analyze the interplay between incentives, behavior, cost structures, governance risk and strategic durability in emerging markets. Complexity academic level The case is designed for Master’s-level and executive audiences. It is best suited to: Subject code CSS 11: Strategy.

Emerald Emerging Markets Case StudiesVol. 16(4)
Sukkur IBA University (PK)
Business Strategies and Innovation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon